Abstract
Background: The potential role of fibroblast activation protein-alpha (FAP) in modulating the progression and invasion of stomach adenocarcinoma (STAD) has not yet been comprehensively investigated. This study aimed to explore the role of FAP in STAD and the underlying association between FAP and the tumor microenvironment (TME) and ferroptosis. Methods: Overall survival was analyzed to evaluate the prognostic value of FAP based on gene expression data and clinical information on STAD. Associations between FAP expression, clinical parameters, and immune characteristics were comprehensively analyzed. The ferroptosis-related patterns of STAD samples were investigated based on 43 ferroptosis-related genes, and the correlations between these clusters and clinical characteristics were evaluated. The possible biological functions and pathways were explored using gene set enrichment analysis (GSEA). Results: FAP was identified as a novel biomarker that significantly contributed to the poor prognosis of STAD (hazard ratio = 1.270, P = 0.013). The elevated level of FAP expression was related to a more advanced tumor stage in STAD. The close relationship between FAP and the TME was validated. Four distinct ferroptosis-related clusters (A–D) were evident. Evaluating ferroptosis-related clusters could illustrate the stages of STAD and patient prognosis. Cluster C displayed the lowest FAP expression and a better prognosis than the other clusters. The different clusters were linked to different biological mechanisms, including epithelial-mesenchymal transition and immune-relevant pathways. Conclusion: FAP is a promising biomarker to distinguish prognosis and is associated with the TME and ferroptosis in STAD.
Highlights
Stomach adenocarcinoma (STAD) is a globally important disease
Fibroblast activation protein-alpha (FAP) was identified as a novel biomarker that significantly contributed to the poor prognosis of STAD
The correlation between FAP and immune checkpoint genes could be evaluated based on the expression of more than 40 immune checkpoint genes generally found in different kinds of cancers
Summary
Stomach adenocarcinoma (STAD) is a globally important disease. Fibroblast activation protein-alpha (FAP) was abundantly and stably expressed in cancer-associated fibroblasts (CAFs) in the cancer stroma. FAP was composed of extracellular domain, single transmembrane domain, and a cytoplasmic tail. It cleaves the post-proline peptide bond while harboring both dipeptidyl peptidase and endopeptidase activities (Aertgeerts et al, 2005; Simkova, Busek, Sedo, and Konvalinka, 2020). F. Wang et al, 2013) documented the positive association of the overexpression of FAP in CAFs with STAD invasive depth, differentiation, Lauren classification, and TNM classification. The potential role of fibroblast activation protein-alpha (FAP) in modulating the progression and invasion of stomach adenocarcinoma (STAD) has not yet been comprehensively investigated. This study aimed to explore the role of FAP in STAD and the underlying association between FAP and the tumor microenvironment (TME) and ferroptosis
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
